Professional Summary

Professional Overview

Zain Kassam is an accomplished medical and healthcare executive with extensive experience in the biotechnology and life sciences industries. As the Chief Medical Officer at Seed Health, he oversees the company's clinical and regulatory strategy, driving the development and commercialization of innovative microbiome-based products.

Experience Summary

Current Role

As the Chief Medical Officer at Seed Health, Zain is responsible for leading the company's clinical and regulatory initiatives. He plays a pivotal role in advancing the organization's pipeline of microbiome-based therapeutics and diagnostics, leveraging his deep expertise in gastroenterology and the human microbiome.

Career Progression

Prior to joining Seed Health, Zain served as the Chief Medical Officer and Co-Founder of Finch Therapeutics Group, where he spearheaded the development of novel microbiome-based therapies. He also held the role of Chief Medical Officer and Founding Team Member at OpenBiome, a pioneering nonprofit organization focused on fecal microbiota transplantation. Earlier in his career, Zain completed a clinical fellowship in Gastroenterology at McMaster University and a residency in Internal Medicine, also at McMaster University.

Academic Background

Zain holds a medical degree and has completed extensive postgraduate training, including a Postdoctoral Research Associate position at the Massachusetts Institute of Technology (MIT). His specialized expertise in gastroenterology and the human microbiome has been a driving force behind his successful career in the biotechnology industry.

Areas of Expertise

• Microbiome-based therapeutics and diagnostics

• Gastroenterology and internal medicine

• Clinical development and regulatory strategy

• Venture capital consulting and strategic advisory

• Founding and scaling biotechnology startups

Professional Impact

Throughout his career, Zain has made significant contributions to the advancement of microbiome-based therapies and diagnostics. He has been instrumental in the development and commercialization of innovative products that have the potential to transform the treatment of various gastrointestinal and metabolic disorders. Zain's strategic vision, medical expertise, and entrepreneurial spirit have positioned him as a highly respected leader in the biotechnology industry.

Conclusion

With his extensive experience, deep medical expertise, and proven track record of success, Zain Kassam is well-positioned to continue driving meaningful progress in the microbiome-based healthcare space. As the Chief Medical Officer at Seed Health, he is poised to make a lasting impact on patient outcomes and contribute to the advancement of the industry as a whole.